CircRNA_100782 promotes roliferation and metastasis of gastric most cancers by downregulating tumor suppressor gene Rb by adsorbing miR-574-3p in a sponge type
Goal: The goal of this research is to analyze the expression ranges of circRNA_100782 in gastric most cancers tissues, and its perform of regulating tumor suppressor gene Rb by absorbing miR-574-3p in a sponge type.
Sufferers and strategies: qRT-PCR was carried out to detect the expressions of circRNA_100782 at totally different phases throughout gastric most cancers tissues. CCK-Eight assay was carried out to guage the osteoclast proliferation and differentiation. The correlation between miR-574-3p and circRNA_100782 was detected by statistical evaluation. Bioinformatics and Luciferase assay have been carried out to discover the interplay and binding website of circRNA_100782 and miR-574-3p. The mice Rb 3′-UTR have been cloned into the Luciferase reporter vector and miR-574-3p binding mutants have been constructed to validate the inhibited regulation of miR-574-3p to the expression of Rb.
Outcomes: Within the present research, in contrast with adjoining non-cancerous regular tissues, the expressions of circRNA_100782 and Rb have been each downregulated in human gastric most cancers cells. By means of qRT-PCR and CCK-Eight assay, we discovered that the expression of circRNA_100782 is expounded to the proliferation of gastric most cancers cells. In addition to, we additionally discovered that circRNA_100782 regulated the migration capability of gastric most cancers cells by transwell assay.
The bioinformatics prediction and luciferase assay demonstrated that circRNA_100782 can function a molecular sponge to additional regulate the expression of Rb by sponging with miR-574-3p; furthermore, circRNA_100782 can function a ceRNA for miR-574-3p to additional regulate the expression of Rb.
Conclusions: On this analysis, we found that circRNA_100782 was downregulated in gastric most cancers cells and is related to cell proliferation and invasion by inhibiting tumor suppressor gene Rb by interacting with miR-574-3p.

Olaparib |
|||
1952-25 | Biovision | EUR 392 |
Olaparib |
|||
1952-5 | Biovision | EUR 147 |
Olaparib (AZD2281) |
|||
E1KS1060 | EnoGene | 10mg | EUR 444 |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-10 | ApexBio | 10 mg | EUR 108 |
Description: Olaparib (4-(3-4-fluorophenyl) methyl-1(2H)-one), as known as AZD2281 or KU0059436, is a novel, selective and potent inhibitor of both poly adenosine diphosphate-ribose polymeras-1 (PARP-1) and poly adenosine diphosphate-ribose polymeras-2 (PARP-2). |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-100 | ApexBio | 100 mg | EUR 235 |
Description: Olaparib (4-(3-4-fluorophenyl) methyl-1(2H)-one), as known as AZD2281 or KU0059436, is a novel, selective and potent inhibitor of both poly adenosine diphosphate-ribose polymeras-1 (PARP-1) and poly adenosine diphosphate-ribose polymeras-2 (PARP-2). |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
Description: Olaparib (4-(3-4-fluorophenyl) methyl-1(2H)-one), as known as AZD2281 or KU0059436, is a novel, selective and potent inhibitor of both poly adenosine diphosphate-ribose polymeras-1 (PARP-1) and poly adenosine diphosphate-ribose polymeras-2 (PARP-2). |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-500 | ApexBio | 500 mg | EUR 780 |
Description: Olaparib (4-(3-4-fluorophenyl) methyl-1(2H)-one), as known as AZD2281 or KU0059436, is a novel, selective and potent inhibitor of both poly adenosine diphosphate-ribose polymeras-1 (PARP-1) and poly adenosine diphosphate-ribose polymeras-2 (PARP-2). |
Olaparib (AZD2281, Ku-0059436) |
|||
A4154-S | ApexBio | Evaluation Sample | EUR 81 |
Description: Olaparib (4-(3-4-fluorophenyl) methyl-1(2H)-one), as known as AZD2281 or KU0059436, is a novel, selective and potent inhibitor of both poly adenosine diphosphate-ribose polymeras-1 (PARP-1) and poly adenosine diphosphate-ribose polymeras-2 (PARP-2). |
Preconditioning Impact of Excessive-Depth Interval Coaching (HIIT) and Berberine Supplementation on the Gene Expression of Angiogenesis Regulators and Caspase-Three Protein within the Rats with Myocardial Ischemia-Reperfusion (IR) Harm
Goal: It has been proven that angiogenesis is a fascinating therapy for sufferers with ischemic coronary heart illness. We got down to examine the affect of high-intensity interval coaching (HIIT) and berberine supplementation on the gene expression of angiogenesis-related components and caspase-Three protein in rats affected by myocardial ischemic-reperfusion harm.
Strategies: Fifty rats have been divided into the next teams: (1) skilled, (2) berberine supplemented, (3) mixed, and (4) IR. Every cohort underwent 5 periods of HIIT per week for a period of Eight weeks adopted by induction of ischemia. Seven days after completion of reperfusion, modifications within the gene expression of angiogenesis-related components and caspase-Three protein have been evaluated within the coronary heart tissue.
Outcomes: We noticed a major distinction between 4 teams within the transcript ranges of vascular endothelial cell development issue (VEGF), fibroblast development factor-2 (FGF2), and thrombospondin-1(TSP-1) (p ≤ 0.05). Nevertheless, the distinction in endostatin (ENDO) ranges was not vital among the many teams regardless of a discernible discount (p ≥ 0.05). Furthermore, caspase-Three protein and infarct dimension have been considerably lowered within the intervention teams (p ≤ 0.05), and cardiac perform elevated in response to those interventions.
Conclusion: The therapies exert their impact, doubtless, by decreasing caspase-Three protein and growing the expression of angiogenesis-promoting components, concomitant with a discount in inhibitors of the method.
Particular miRNA and Gene Deregulation Characterize the Elevated Angiogenic Transforming of Thoracic Aneurysmatic Aortopathy in Marfan Syndrome
Marfan syndrome (MFS) is a connective tissue illness brought on by mutations within the FBN1 gene, resulting in alterations within the extracellular matrix microfibril meeting and the early formation of thoracic aorta aneurysms (TAAs). Non-genetic TAAs share many clinico-pathological elements with MFS and deregulation of some microRNAs (miRNAs) has been demonstrated to be concerned within the development of TAA. On this research, 40 sufferers present process elective ascending aorta surgical procedure have been enrolled to match TAA histomorphological options, miRNA profile and associated goal genes with the intention to discover particular alterations that will clarify the sooner and extra extreme scientific outcomes in MFS sufferers.
Histomorphological, ultrastructural and in vitro research have been carried out with the intention to evaluate aortic wall options of MFS and non-MFS TAA. MFS displayed better glycosaminoglycan accumulation and loss/fragmentation of elastic fibers in comparison with non-MFS TAA. Immunohistochemistry revealed elevated CD133+ angiogenic reworking, better MMP-2 expression, irritation and {smooth} muscle cell (SMC) turnover in MFS TAA.
Cultured SMCs from MFS confirmed increased turnover and α-smooth muscle actin expression in contrast with non-MFS TAA. Furthermore, twenty-five miRNAs, together with miR-26a, miR-29, miR-143 and miR-145, have been discovered to be downregulated and solely miR-632 was upregulated in MFS TAA in vivo.
Bioinformatics evaluation revealed that some deregulated miRNAs in MFS TAA are implicated in cell proliferation, extracellular matrix construction/perform and TGFβ signaling. Lastly, gene evaluation confirmed 28 upregulated and 7 downregulated genes in MFS TAA, a few of them belonging to the CDH1/APC and CCNA2/TP53 signaling pathways. Particular miRNA and gene deregulation characterised the aortopathy of MFS and this was related to elevated angiogenic reworking, doubtless favoring the early and extra extreme scientific outcomes, in comparison with non-MFS TAA.
Our findings present new insights in regards to the pathogenetic mechanisms of MFS TAA; additional investigation is required to substantiate if these newly recognized particular deregulated miRNAs could symbolize potential therapeutic targets to counteract the speedy development of MFS aortopathy.
Mouse Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 489 |
Mouse Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 677 |
Mouse Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 511 |
Mouse Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 709 |
Bovine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-b-48T | DL Develop | 48T | EUR 547 |
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Alpha-Fetoprotein (aFP) in samples from serum, plasma or other biological fluids. |
Bovine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-b-96T | DL Develop | 96T | EUR 715 |
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Alpha-Fetoprotein (aFP) in samples from serum, plasma or other biological fluids. |
Canine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-c-48T | DL Develop | 48T | EUR 527 |
Description: A sandwich quantitative ELISA assay kit for detection of Canine Alpha-Fetoprotein (aFP) in samples from serum, plasma or other biological fluids. |
Canine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-c-96T | DL Develop | 96T | EUR 688 |
Description: A sandwich quantitative ELISA assay kit for detection of Canine Alpha-Fetoprotein (aFP) in samples from serum, plasma or other biological fluids. |
Equine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Eq-48T | DL Develop | 48T | EUR 556 |
Description: A sandwich quantitative ELISA assay kit for detection of Equine Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Equine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Eq-96T | DL Develop | 96T | EUR 728 |
Description: A sandwich quantitative ELISA assay kit for detection of Equine Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Hu-48T | DL Develop | 48T | EUR 366 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Hu-96T | DL Develop | 96T | EUR 465 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-p-48T | DL Develop | 48T | EUR 547 |
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-p-96T | DL Develop | 96T | EUR 715 |
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Ra-48T | DL Develop | 48T | EUR 508 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Ra-96T | DL Develop | 96T | EUR 661 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Monkey Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Si-48T | DL Develop | 48T | EUR 576 |
Description: A sandwich quantitative ELISA assay kit for detection of Monkey Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Monkey Alpha-Fetoprotein (aFP) ELISA Kit |
|||
DLR-aFP-Si-96T | DL Develop | 96T | EUR 755 |
Description: A sandwich quantitative ELISA assay kit for detection of Monkey Alpha-Fetoprotein (aFP) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-b-48Tests | Reddot Biotech | 48 Tests | EUR 555 |
Bovine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-b-96Tests | Reddot Biotech | 96 Tests | EUR 771 |
Canine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-c-48Tests | Reddot Biotech | 48 Tests | EUR 533 |
Canine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-c-96Tests | Reddot Biotech | 96 Tests | EUR 740 |
Equine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Eq-48Tests | Reddot Biotech | 48 Tests | EUR 566 |
Equine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Eq-96Tests | Reddot Biotech | 96 Tests | EUR 787 |
Human Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 350 |
Human Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 479 |
Porcine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-p-48Tests | Reddot Biotech | 48 Tests | EUR 555 |
Porcine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-p-96Tests | Reddot Biotech | 96 Tests | EUR 771 |
Rat Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 511 |
Rat Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 709 |
Monkey Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Si-48Tests | Reddot Biotech | 48 Tests | EUR 587 |
Monkey Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RD-aFP-Si-96Tests | Reddot Biotech | 96 Tests | EUR 818 |
Bovine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-b-48Tests | Reddot Biotech | 48 Tests | EUR 580 |
Bovine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-b-96Tests | Reddot Biotech | 96 Tests | EUR 807 |
Canine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-c-48Tests | Reddot Biotech | 48 Tests | EUR 557 |
Canine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-c-96Tests | Reddot Biotech | 96 Tests | EUR 774 |
Equine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Eq-48Tests | Reddot Biotech | 48 Tests | EUR 591 |
Equine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Eq-96Tests | Reddot Biotech | 96 Tests | EUR 823 |
Human Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 365 |
Human Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 500 |
Porcine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-p-48Tests | Reddot Biotech | 48 Tests | EUR 580 |
Porcine Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-p-96Tests | Reddot Biotech | 96 Tests | EUR 807 |
Rat Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 534 |
Rat Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 742 |
Monkey Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Si-48Tests | Reddot Biotech | 48 Tests | EUR 614 |
Monkey Alpha-Fetoprotein (aFP) ELISA Kit |
|||
RDR-aFP-Si-96Tests | Reddot Biotech | 96 Tests | EUR 856 |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Bo01 | Cloud-Clone |
|
|
Description: Recombinant Bovine Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Ca01 | Cloud-Clone |
|
|
Description: Recombinant Dog Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Hu02 | Cloud-Clone |
|
|
Description: Recombinant Human Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Po01 | Cloud-Clone |
|
|
Description: Recombinant Pig Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Po02 | Cloud-Clone |
|
|
Description: Recombinant Pig Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Po03 | Cloud-Clone |
|
|
Description: Recombinant Pig Alpha-Fetoprotein expressed in: E.coli |
Recombinant Alpha-Fetoprotein (aFP) |
|||
4-RPA153Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Alpha-Fetoprotein expressed in: E.coli |
Mouse Alpha-fetoprotein (Afp) |
|||
1-CSB-YP001421MO | Cusabio |
|
|
Description: Recombinant Mouse Alpha-fetoprotein(Afp) expressed in Yeast |
Mouse Alpha-fetoprotein (Afp) |
|||
1-CSB-EP001421MO | Cusabio |
|
|
Description: Recombinant Mouse Alpha-fetoprotein(Afp) expressed in E.coli |
Mouse Alpha-fetoprotein (Afp) |
|||
1-CSB-EP001421MOe1 | Cusabio |
|
|
Description: Recombinant Mouse Alpha-fetoprotein(Afp) expressed in E.coli |
Mouse Alpha-Fetoprotein (aFP) Protein |
|||
20-abx065265 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Mouse mAb |
|||
A11865 | Abclonal | 20 μL | EUR 15 |
AFP Alpha-Fetoprotein Human |
|||
PROTP02771 | BosterBio | Regular: 50ug | EUR 317 |
Description: Human alpha-fetoprotein purified from human cord serum, shows a 70kDa band on SDS-PAGE. |
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx129944 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
abx125411-50ul | Abbexa | 50 ul | EUR 411 |
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx125498 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx128500 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx116775 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx123962 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx104868 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx109521 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx109522 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx110374 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx101417 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx101418 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx101419 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx101420 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx101421 | Abbexa |
|
|
Alpha-Fetoprotein (aFP) Antibody |
|||
20-abx101422 | Abbexa |
|
|
Alpha Fetoprotein (AFP) Protein |
|||
abx061589-1mg | Abbexa | 1 mg | EUR 829 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx037404-100ug | Abbexa | 100 ug | EUR 391 |
Alpha-Fetoprotein (AFP) Antibody |
|||
20-abx000589 | Abbexa |
|
|
Alpha-Fetoprotein (AFP) Antibody |
|||
abx025195-400ul | Abbexa | 400 ul | EUR 523 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx025195-80l | Abbexa | 80 µl | EUR 286 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx025196-100ul | Abbexa | 100 ul | EUR 523 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx015762-100ul | Abbexa | 100 ul | EUR 411 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx018327-100ug | Abbexa | 100 ug | EUR 439 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx019011-100ug | Abbexa | 100 ug | EUR 342 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020102-100ug | Abbexa | 100 ug | EUR 439 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020507-1mg | Abbexa | 1 mg | EUR 662 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020508-1mg | Abbexa | 1 mg | EUR 453 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020509-1mg | Abbexa | 1 mg | EUR 453 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020510-1mg | Abbexa | 1 mg | EUR 648 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020512-1mg | Abbexa | 1 mg | EUR 648 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020513-1mg | Abbexa | 1 mg | EUR 690 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020514-1mg | Abbexa | 1 mg | EUR 481 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020515-1mg | Abbexa | 1 mg | EUR 739 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx020561-1mg | Abbexa | 1 mg | EUR 481 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx022523-1mg | Abbexa | 1 mg | EUR 453 |
Alpha-Fetoprotein (AFP) Antibody |
|||
abx022524-1mg | Abbexa | 1 mg | EUR 453 |